OBJECTIVES: to determine limitations and strengths of three methodologies developed to estimate HIV prevalence and the number of people living with HIV/AIDS (PLWHA). METHODS: the UNAIDS/WHO Workbook method; the Multiparameter Evidence Synthesis (MPES) adopted by the Health Protection Agency; and the UNAIDS/WHO Estimation and Projection Package (EPP) and Spectrum method were used and their applicability and feasibility were assessed. All methods estimate the number infected in mutually exclusive risk groups among 15-70-year-olds. RESULTS: using data from the Netherlands, the Workbook method estimated 23 969 PLWHA as of January 2008. MPES estimated 21 444 PLWHA, with a 95% credible interval (CrI) of 17 204-28 694. Adult HIV prevalence was estimated at 0.2% (95% CrI 0.15-0.24%) and 40% (95% CrI 25-55%) were undiagnosed. Spectrum applied gender-specific mortality, resulting in a projected estimate of 19 115 PLWHA. CONCLUSION: although outcomes differed between the methods, they broadly concurred. An advantage of MPES is that the proportion diagnosed can be estimated by risk group, which is important for policy guidance. However, before MPES can be used on a larger scale, it should be made more easily applicable. If the aim is not only to obtain annual estimates, but also short-term projections, then EPP and Spectrum are more suitable. Research into developing and refining analytical tools, which make use of all available information, is recommended, especially HIV diagnosed cases, as this information is becoming routinely collected in most countries with concentrated HIV epidemics. 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins.
OBJECTIVES: to determine limitations and strengths of three methodologies developed to estimate HIV prevalence and the number of people living with HIV/AIDS (PLWHA). METHODS: the UNAIDS/WHO Workbook method; the Multiparameter Evidence Synthesis (MPES) adopted by the Health Protection Agency; and the UNAIDS/WHO Estimation and Projection Package (EPP) and Spectrum method were used and their applicability and feasibility were assessed. All methods estimate the number infected in mutually exclusive risk groups among 15-70-year-olds. RESULTS: using data from the Netherlands, the Workbook method estimated 23 969 PLWHA as of January 2008. MPES estimated 21 444 PLWHA, with a 95% credible interval (CrI) of 17 204-28 694. Adult HIV prevalence was estimated at 0.2% (95% CrI 0.15-0.24%) and 40% (95% CrI 25-55%) were undiagnosed. Spectrum applied gender-specific mortality, resulting in a projected estimate of 19 115 PLWHA. CONCLUSION: although outcomes differed between the methods, they broadly concurred. An advantage of MPES is that the proportion diagnosed can be estimated by risk group, which is important for policy guidance. However, before MPES can be used on a larger scale, it should be made more easily applicable. If the aim is not only to obtain annual estimates, but also short-term projections, then EPP and Spectrum are more suitable. Research into developing and refining analytical tools, which make use of all available information, is recommended, especially HIV diagnosed cases, as this information is becoming routinely collected in most countries with concentrated HIV epidemics. 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins.
Authors: Laura Camoni; Mariangela Raimondo; Maria Dorrucci; Vincenza Regine; Maria Cristina Salfa; Barbara Suligoi Journal: AIDS Res Hum Retroviruses Date: 2015-01-06 Impact factor: 2.205
Authors: Eline L M Op de Coul; Imke Schreuder; Stefano Conti; Ard van Sighem; Maria Xiridou; Maaike G Van Veen; Janneke C M Heijne Journal: PLoS One Date: 2015-07-17 Impact factor: 3.240
Authors: Fleur van Aar; Imke Schreuder; Yolanda van Weert; Ralph Spijker; Hannelore Götz; Eline Op de Coul Journal: BMC Infect Dis Date: 2012-05-14 Impact factor: 3.090
Authors: Ana B Abecasis; Annemarie M J Wensing; Dimitris Paraskevis; Jurgen Vercauteren; Kristof Theys; David A M C Van de Vijver; Jan Albert; Birgitta Asjö; Claudia Balotta; Danail Beshkov; Ricardo J Camacho; Bonaventura Clotet; Cillian De Gascun; Algis Griskevicius; Zehava Grossman; Osamah Hamouda; Andrzej Horban; Tatjana Kolupajeva; Klaus Korn; Leon G Kostrikis; Claudia Kücherer; Kirsi Liitsola; Marek Linka; Claus Nielsen; Dan Otelea; Roger Paredes; Mario Poljak; Elisabeth Puchhammer-Stöckl; Jean-Claude Schmit; Anders Sönnerborg; Danika Stanekova; Maja Stanojevic; Daniel Struck; Charles A B Boucher; Anne-Mieke Vandamme Journal: Retrovirology Date: 2013-01-14 Impact factor: 4.602
Authors: Dineke Frentz; Annemarie M J Wensing; Jan Albert; Dimitrios Paraskevis; Ana B Abecasis; Osamah Hamouda; Louise B Jørgensen; Claudia Kücherer; Daniel Struck; Jean-Claude Schmit; Birgitta Åsjö; Claudia Balotta; Danail Beshkov; Ricardo J Camacho; Bonaventura Clotet; Suzie Coughlan; Stéphane De Wit; Algirdas Griskevicius; Zehava Grossman; Andrzej Horban; Tatjana Kolupajeva; Klaus Korn; Leondios G Kostrikis; Kirsi Liitsola; Marek Linka; Claus Nielsen; Dan Otelea; Roger Paredes; Mario Poljak; Elisabeth Puchhammer-Stöckl; Anders Sönnerborg; Danica Stanekova; Maja Stanojevic; Anne-Mieke Vandamme; Charles A B Boucher; David A M C Van de Vijver Journal: Retrovirology Date: 2013-04-03 Impact factor: 4.602
Authors: Daniel Chemtob; Eline Op de Coul; Ard van Sighem; Zohar Mor; Françoise Cazein; Caroline Semaille Journal: Isr J Health Policy Res Date: 2015-08-04